Acute ischemic stroke management: concepts and controversies.A narrative review

References

• Group GNDC. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol. 2017; 16:877–897. [published Online First: 2017/09/22].
   PubMed Web of Science ®Google Scholar
• Yan LL, Li C, Chen J, et al. Chapter 9 stroke. Cardiovascular, respiratory, and related disorders. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2017.
   Google Scholar
• Donnan GA, Fisher M, Macleod M, et al. Stroke. Lancet. 2008;371:1612–1623. [published Online First: 2008/05/13].
   PubMed Web of Science ®Google Scholar
• Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American heart association/american stroke association stroke council; council on cardiovascular surgery and anesthesia; council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease. The American academy of neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40:2276–2293. [published Online First: 2009/05/09].
   PubMed Web of Science ®Google Scholar
• Collaborators GS. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18:439–458. [published Online First: 2019/03/16]. DOI:10.1016/s1474-4422(19)30034-1
   PubMed Web of Science ®Google Scholar
• Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin. 2008;26:871–95,vii. [published Online First: 2008/11/26].
   PubMed Web of Science ®Google Scholar
• Shuaib A, Hachinski VC. Mechanisms and management of stroke in the elderly. CMAJ. 1991;145:433–443. [published Online First: 1991/09/01].
   PubMed Web of Science ®Google Scholar
• Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352:1791–1798. [published Online First: 2005/04/29].
   PubMed Web of Science ®Google Scholar
• Group NIoNDaSr-PSS. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581–1587. [published Online First: 1995/12/14].
   PubMed Web of Science ®Google Scholar
• Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet. 2007;369:275–282. [published Online First: 2007/01/30].
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–1329. [published Online First: 2008/09/26].
   PubMed Web of Science ®Google Scholar
• Anderson CS, Robinson T, Lindley RI, et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med. 2016;374:2313–2323. [published Online First: 2016/05/11].
   PubMed Web of Science ®Google Scholar
• Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012;379:2352–2363. [published Online First: 2012/05/29].
   PubMed Web of Science ®Google Scholar
• Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384:1929–1935. [published Online First: 2014/08/12].
   PubMed Web of Science ®Google Scholar
• Campbell BCV, Ma H, Ringleb PA, et al. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet. 2019;394:139–147. [published Online First: 2019/05/28].
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Mori E, Minematsu K, et al. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan alteplase clinical trial (J-ACT). Stroke. 2006;37:1810–1815. [published Online First: 2006/06/10].
   PubMed Web of Science ®Google Scholar
• Whiteley WN, Slot KB, Fernandes P, et al. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke. 2012;43:2904–2909. [published Online First: 2012/09/22].
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Katsanos AH, Mavridis D, et al. Intravenous thrombolysis for ischemic stroke patients on dual antiplatelets. Ann Neurol. 2018;84:89–97. [published Online First: 2018/07/27].
   PubMed Web of Science ®Google Scholar
• Siedler G, Sommer K, Macha K, et al. Heart failure in ischemic stroke: relevance for acute care and outcome. Stroke. 2019;50:3051–3056. [published Online First: 2019/09/29].
   PubMed Web of Science ®Google Scholar
• Findler M, Molad J, Bornstein NM, et al. Worse outcome in patients with acute stroke and atrial fibrillation following thrombolysis. Isr Med Assoc J. 2017;19:293–295.. [published Online First: 2017/05/18].
   PubMed Web of Science ®Google Scholar
• Pollack CV Jr., Reilly PA, Eikelboom J, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373:511–520. [published Online First: 2015/06/23].
   PubMed Web of Science ®Google Scholar
• Shahjouei S, Tsivgoulis G, Goyal N, et al. Safety of intravenous thrombolysis among patients taking direct oral anticoagulants: a systematic review and meta-analysis. Stroke. 2020;51:533–541. [published Online First: 2019/12/31].
   PubMed Web of Science ®Google Scholar
• Šaňák D, Jakubíček S, Černík D, et al. Intravenous thrombolysis in patients with acute ischemic stroke after a reversal of dabigatran anticoagulation with idarucizumab: a real-world clinical experience. J Stroke Cerebrovasc Dis. 2018;27:2479–2483. [published Online First: 2018/05/29].
   PubMed Web of Science ®Google Scholar
• Toyoda K, Yamagami H, Koga M. Consensus guides on stroke thrombolysis for anticoagulated patients from Japan: application to other populations. J Stroke. 2018;20:321–331. [published Online First: 2018/10/13].
   PubMed Web of Science ®Google Scholar
• Chausson N, Soumah D, Aghasaryan M, et al. Reversal of vitamin K antagonist therapy before thrombolysis for acute ischemic stroke. Stroke. 2018;49:2526–2528. [published Online First: 2018/10/26].
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2018;49:e46–e110. [published Online First: 2018/01/26].
   PubMed Web of Science ®Google Scholar
• Haley EC Jr., Thompson JL, Grotta JC, et al. Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke. 2010;41:707–711. [published Online First: 2010/02/27].
   PubMed Web of Science ®Google Scholar
• Parsons M, Spratt N, Bivard A, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012;366:1099–1107. [published Online First: 2012/03/23].
   PubMed Web of Science ®Google Scholar
• Huang X, Cheripelli BK, Lloyd SM, et al. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study. Lancet Neurol. 2015;14:368–376. [published Online First: 2015/03/03].
   PubMed Web of Science ®Google Scholar
• Logallo N, Novotny V, Assmus J, et al. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol. 2017;16:781–788. [published Online First: 2017/08/07]. DOI:10.1016/s1474-4422(17)30253-3
   PubMed Web of Science ®Google Scholar
• Campbell BCV, Mitchell PJ, Churilov L, et al. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. N Engl J Med. 2018;378:1573–1582.
   PubMed Web of Science ®Google Scholar
• Burgos AM, Saver JL. Evidence that tenecteplase is noninferior to alteplase for acute ischemic stroke: meta-analysis of 5 randomized trials. Stroke. 2019;50:2156–2162. [published Online First: 2019/07/19].
   PubMed Web of Science ®Google Scholar
• Zitek T, Ataya R, Brea I. Using tenecteplase for acute ischemic stroke: what is the hold up? West J Emerg Med. 2020;21:199–202. [published Online First: 2020/03/20].
   PubMed Web of Science ®Google Scholar
• Campbell BC, Mitchell PJ, Churilov L, et al. Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study. Int J Stroke. 2020;15:567–572. [published Online First: 2019/10/01].
   PubMed Web of Science ®Google Scholar
• Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893–903. [published Online First: 2013/02/09].
   PubMed Web of Science ®Google Scholar
• Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368:904–913. [published Online First: 2013/02/08].
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914–923. [published Online First: 2013/02/12].
   PubMed Web of Science ®Google Scholar
• Christou I, Burgin WS, Alexandrov AV, et al. Arterial status after intravenous TPA therapy for ischaemic stroke. A need for further interventions. Int Angiol. 2001;20:208–213. [published Online First: 2001/09/27].
   PubMed Web of Science ®Google Scholar
• Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20. [published Online First: 2014/12/18].
   PubMed Web of Science ®Google Scholar
• Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–1018. [published Online First: 2015/02/12].
   PubMed Web of Science ®Google Scholar
• Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–1030. [published Online First: 2015/02/12].
   PubMed Web of Science ®Google Scholar
• Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–2295. [published Online First: 2015/04/18].
   PubMed Web of Science ®Google Scholar
• Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–2306. [published Online First: 2015/04/18].
   PubMed Web of Science ®Google Scholar
• Chen CJ, Ding D, Starke RM, et al. Endovascular vs medical management of acute ischemic stroke. Neurology. 2015;85:1980–1990. [published Online First: 2015/11/06].
   PubMed Web of Science ®Google Scholar
• Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723–1731. [published Online First: 2016/02/24].
   PubMed Web of Science ®Google Scholar
• Alonso de Leciñana M, Martínez-Sánchez P, García-Pastor A, et al. Mechanical thrombectomy in patients with medical contraindications for intravenous thrombolysis: a prospective observational study. J Neurointerv Surg. 2017;9:1041–1046. [published Online First: 2016/11/09].
   PubMed Web of Science ®Google Scholar
• Yang P, Zhang Y, Zhang L, et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med. 2020;382:1981–1993.
   PubMed Web of Science ®Google Scholar
• Bridging thrombolysis versus direct mechanical thrombectomy in acute ischemic stroke. [cited 2020 Aug 26]. Available from: https://ClinicalTrials.gov/show/NCT03192332.
   Google Scholar
• The TESLA trial: thrombectomy for emergent salvage of large anterior circulation ischemic stroke. [cited 2020 Aug 26]. Available from: https://ClinicalTrials.gov/show/NCT03805308.
   Google Scholar
• Endovascular therapy for low NIHSS ischemic strokes. [cited 2020 Aug 26]. Available from: https://ClinicalTrials.gov/show/NCT04167527.
   Google Scholar
• Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012;11:860–867. [published Online First: 2012/09/08].
   PubMed Web of Science ®Google Scholar
• Takasawa M, Jones PS, Guadagno JV, et al. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke. 2008;39:870–877. [published Online First: 2008/02/09].
   PubMed Web of Science ®Google Scholar
• Lin L, Bivard A, Levi CR, et al. Comparison of computed tomographic and magnetic resonance perfusion measurements in acute ischemic stroke: back-to-back quantitative analysis. Stroke. 2014;45:1727–1732. [published Online First: 2014/05/31].
   PubMed Web of Science ®Google Scholar
• Pepper EM, Parsons MW, Bateman GA, et al. CT perfusion source images improve identification of early ischaemic change in hyperacute stroke. J Clin Neurosci. 2006;13:199–205. [published Online First: 2006/02/07].
   PubMed Web of Science ®Google Scholar
• Kucinski T, Koch C, Eckert B, et al. Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic stroke. Neuroradiology. 2003;45:11–18. [published Online First: 2003/01/15].
   PubMed Web of Science ®Google Scholar
• Buchman SL, Merkler AE. Basilar artery occlusion: diagnosis and acute treatment. Curr Treat Options Neurol. 2019;21:45. [published Online First: 2019/09/27].
   PubMed Web of Science ®Google Scholar
• van der Hoeven EJ, Schonewille WJ, Vos JA, et al. The basilar artery international cooperation study (BASICS): study protocol for a randomised controlled trial. Trials. 2013;14:200. [published Online First: 2013/07/10].
   PubMedGoogle Scholar
• Mak CH, Ho JW, Chan KY, et al. Intra-arterial revascularization therapy for basilar artery occlusion-a systematic review and analysis. Neurosurg Rev. 2016;39:575–580. [published Online First: 2016/01/27].
   PubMed Web of Science ®Google Scholar
• Gory B, Eldesouky I, Sivan-Hoffmann R, et al. Outcomes of stent retriever thrombectomy in basilar artery occlusion: an observational study and systematic review. J Neurol Neurosurg Psychiatry. 2016;87:520–525. [published Online First: 2015/05/20].
   PubMed Web of Science ®Google Scholar
• Wyszomirski A, Szczyrba S, Tomaka D, et al. Treatment of acute basilar artery occlusion: systematic review and meta-analysis. Neurol Neurochir Pol. 2017;51:486–496. [published Online First: 2017/08/22].
   PubMed Web of Science ®Google Scholar
• Zi W, Qiu Z, Wu D, et al. Assessment of endovascular treatment for acute basilar artery occlusion via a nationwide prospective registry. JAMA Neurol. 2020;77:561–573. [published Online First: 2020/02/23].
   PubMed Web of Science ®Google Scholar
• Abou-Chebl A, Yeatts SD, Yan B, et al. Impact of general anesthesia on safety and outcomes in the endovascular arm of interventional management of stroke (IMS) III trial. Stroke. 2015;46:2142–2148. [published Online First: 2015/07/04]. DOI:10.1161/strokeaha.115.008761
   PubMed Web of Science ®Google Scholar
• Ilyas A, Chen CJ, Ding D, et al. Endovascular mechanical thrombectomy for acute ischemic stroke under general anesthesia versus conscious sedation: a systematic review and meta-analysis. World Neurosurg. 2018;112:e355–e67. [published Online First: 2018/01/23].
   PubMed Web of Science ®Google Scholar
• Wu L, Jadhav AP, Zhao W, et al. General anesthesia vs local anesthesia during mechanical thrombectomy in acute ischemic stroke. J Neurol Sci. 2019;403:13–18. [published Online First: 2019/06/09].
   PubMed Web of Science ®Google Scholar
• Powers CJ, Dornbos D 3rd, Mlynash M, et al. Thrombectomy with conscious sedation compared with general anesthesia: a DEFUSE 3 analysis. AJNR Am J Neuroradiol. 2019;40:1001–1005. [published Online First: 2019/05/11].
   PubMed Web of Science ®Google Scholar
• Higashida R, Alberts MJ, Alexander DN, et al. Interactions within stroke systems of care: a policy statement from the American heart association/American stroke association. Stroke. 2013;44:2961–2984. [published Online First: 2013/08/31].
   PubMed Web of Science ®Google Scholar
• Zinkstok SM, Roos YB. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet. 2012;380:731–737. [published Online First: 2012/07/04].
   PubMed Web of Science ®Google Scholar
• Sivan-Hoffmann R, Gory B, Rabilloud M, et al. Patient outcomes with stent-retriever thrombectomy for anterior circulation stroke: a meta-analysis and review of the literature. Isr Med Assoc J. 2016;18:561–566. [published Online First: 2017/05/05].
   PubMed Web of Science ®Google Scholar
• Papanagiotou P, Haussen DC, Turjman F, et al. Carotid stenting with antithrombotic agents and intracranial thrombectomy leads to the highest recanalization rate in patients with acute stroke with tandem lesions. JACC Cardiovasc Interventions. 2018;11:1290–1299. [published Online First: 2018/07/07].
   PubMed Web of Science ®Google Scholar
• GJd Z, Saver JL, Jauch EC, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator. Stroke. 2009;40:2945–2948.
   PubMed Web of Science ®Google Scholar
• Albers GW. Late window paradox. Stroke. 2018;49:768–771. [published Online First: 2018/01/26].
   PubMed Web of Science ®Google Scholar
• Murray NM, Unberath M, Hager GD, et al. Artificial intelligence to diagnose ischemic stroke and identify large vessel occlusions: a systematic review. J Neurointerv Surg. 2020;12:156–164. [published Online First: 2019/10/09].
   PubMed Web of Science ®Google Scholar
• Herweh C, Ringleb PA, Rauch G, et al. Performance of e-ASPECTS software in comparison to that of stroke physicians on assessing CT scans of acute ischemic stroke patients. Int J Stroke. 2016;11:438–445. [published Online First: 2016/02/18].
   PubMed Web of Science ®Google Scholar
• Nagel S, Sinha D, Day D, et al. e-ASPECTS software is non-inferior to neuroradiologists in applying the ASPECT score to computed tomography scans of acute ischemic stroke patients. Int J Stroke. 2017;12:615–622. [published Online First: 2016/12/03].
   PubMed Web of Science ®Google Scholar
• Goebel J, Stenzel E, Guberina N, et al. Automated ASPECT rating: comparison between the Frontier ASPECT score software and the brainomix software. Neuroradiology. 2018;60:1267–1272. [published Online First: 2018/09/17].
   PubMed Web of Science ®Google Scholar
• Guberina N, Dietrich U, Radbruch A, et al. Detection of early infarction signs with machine learning-based diagnosis by means of the Alberta stroke program early CT score (ASPECTS) in the clinical routine. Neuroradiology. 2018;60:889–901. [published Online First: 2018/08/02].
   PubMed Web of Science ®Google Scholar
• Seker F, Pfaff J, Nagel S, et al. CT reconstruction levels affect automated and reader-based ASPECTS ratings in acute ischemic stroke. J Neuroimaging. 2019;29:62–64. [published Online First: 2018/09/20].
   PubMed Web of Science ®Google Scholar
• Olive-Gadea M, Martins N, Boned S, et al. Baseline ASPECTS and e-ASPECTS correlation with infarct volume and functional outcome in patients undergoing mechanical thrombectomy. J Neuroimaging. 2019;29:198–202. [published Online First: 2018/09/20].
   PubMed Web of Science ®Google Scholar
• Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378:708–718. [published Online First: 2018/01/25].
   PubMed Web of Science ®Google Scholar
• Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11–21. [published Online First: 2017/11/14].
   PubMed Web of Science ®Google Scholar
• Lansberg MG, Christensen S, Kemp S, et al. Computed tomographic perfusion to predict response to recanalization in ischemic stroke. Ann Neurol. 2017;81:849–856. [published Online First: 2017/05/10].
   PubMed Web of Science ®Google Scholar
• Straka M, Albers GW, Bammer R. Real-time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging. 2010;32:1024–1037. [published Online First: 2010/10/30].
   PubMed Web of Science ®Google Scholar
• Austein F, Riedel C, Kerby T, et al. Comparison of perfusion CT software to predict the final infarct volume after thrombectomy. Stroke. 2016;47:2311–2317. [published Online First: 2016/08/11].
   PubMed Web of Science ®Google Scholar
• Barreira CM, Bouslama M, Haussen DC, et al. Abstract WP61: automated large artery occlusion detection IN stroke imaging - ALADIN study. Stroke. 2018;49(Suppl_1):AWP61–AWP61.
   Google Scholar
• Hankey GJ. Stroke. Lancet. 2017;389:641–654. [published Online First: 2016/09/18].
   PubMed Web of Science ®Google Scholar
• Balami JS, White PM, McMeekin PJ, et al. Complications of endovascular treatment for acute ischemic stroke: prevention and management. Int J Stroke. 2018;13:348–361. [published Online First: 2017/11/25].
   PubMed Web of Science ®Google Scholar
• Collaboration ATs. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ (Clin Res Ed). 2002; 324:71–86. [published Online First: 2002/01/12].
   PubMedGoogle Scholar
• Rothwell PM, Algra A, Chen Z, et al. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet. 2016;388:365–375. [published Online First: 2016/05/23].
   PubMed Web of Science ®Google Scholar
• Johnston SC, Amarenco P, Albers GW, et al. Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med. 2016;375:35–43. [published Online First: 2016/05/11].
   PubMed Web of Science ®Google Scholar
• Paciaroni M, Ince B, Hu B, et al. Benefits and risks of clopidogrel vs. aspirin monotherapy after recent ischemic stroke: a systematic review and meta-analysis. Cardiovasc Ther 2019. 2019: 1607181. [published Online First: 2019/12/24]. DOI:10.1155/2019/1607181
   Google Scholar
• Committee CS. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE steering committee. Lancet. 1996; 348:1329–1339. [published Online First: 1996/11/16].
   PubMed Web of Science ®Google Scholar
• Bath PM, Woodhouse LJ, Appleton JP, et al. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. Lancet. 2018;391:850–859. [published Online First: 2017/12/25].
   PubMed Web of Science ®Google Scholar
• Hao Q, Tampi M, O’Donnell M, et al. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis. BMJ (Clin Res Ed). 2018;363:k5108. [published Online First: 2018/12/20].
   PubMedGoogle Scholar
• Yang Y, Zhou M, Zhong X, et al. Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis. Stroke Vasc Neurol. 2018;3:107–116. [published Online First: 2018/07/20].
   PubMedGoogle Scholar
• Gotoh F, Tohgi H, Hirai S, et al. Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis. 2000;9:147–157. [published Online First: 2000/07/01]. DOI:10.1053/jscd.2000.7216
   PubMedGoogle Scholar
• Shinohara Y, Katayama Y, Uchiyama S, et al. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.. Lancet Neurol. 2010;9:959–968. [published Online First: 2010/09/14].
   PubMed Web of Science ®Google Scholar
• Toyoda K, Uchiyama S, Yamaguchi T, et al. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial. Lancet Neurol. 2019;18:539–548. [published Online First: 2019/05/28].
   PubMed Web of Science ®Google Scholar
• Saxena R, Koudstaal PJ. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2004;Cd000185. [published Online First: 2004/04/24]. DOI:10.1002/14651858.CD000185.pub2
   PubMed Web of Science ®Google Scholar
• Chao TF, Should GY. We adopt a standard international normalized ratio range of 2.0 to 3.0 for asian patients with atrial fibrillation? an appeal for evidence-based management, not eminence-based recommendations. Thromb Haemost. 2020;120:366–368. [published Online First: 2020/03/07].
   PubMed Web of Science ®Google Scholar
• Chao TF, Chen SA, Ruff CT, et al. Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial. Eur Heart J. 2019;40:1518–1527. [published Online First: 2018/12/28].
   PubMedGoogle Scholar
• Group JJW. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013). Circ J. 2014; 78:1997–2021. [published Online First: 2014/06/27].
   PubMed Web of Science ®Google Scholar
• Dalal J, Bhave A, Oomman A, et al. The Indian consensus guidance on stroke prevention in atrial fibrillation: an emphasis on practical use of nonvitamin K oral anticoagulants. Indian Heart J. 2015;67(Suppl 2):S13–34. [published Online First: 2015/12/22].
   PubMedGoogle Scholar
• Pandey AK, Xu K, Zhang L, et al. Lower versus standard INR targets in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Thromb Haemost. 2020;120:484–494. [published Online First: 2020/01/16].
   PubMed Web of Science ®Google Scholar
• McDowell TY, Lawrence J, Florian J, et al. Relationship between international normalized ratio and outcomes in modern trials with warfarin controls. Pharmacotherapy. 2018;38:899–906. [published Online First: 2018/06/20].
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263–272. [published Online First: 2009/09/19]. DOI:10.1378/chest.09-1584
   PubMed Web of Science ®Google Scholar
• Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey. Chest. 2010;138:1093–1100. [published Online First: 2010/03/20].
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–1151. [published Online First: 2009/09/01].
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Wallentin L, Yusuf S. Additional events in the RE-LY trial. N Engl J Med. 2014;371:1464–1465. [published Online First: 2014/09/25].
   PubMed Web of Science ®Google Scholar
• Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093–2104. [published Online First: 2013/11/21].
   PubMed Web of Science ®Google Scholar
• Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–992. [published Online First: 2011/08/30].
   PubMed Web of Science ®Google Scholar
• Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–891. [published Online First: 2011/08/13].
   PubMed Web of Science ®Google Scholar
• Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955–962. [published Online First: 2013/12/10].
   PubMed Web of Science ®Google Scholar
• Wang KL, Lip GY, Lin SJ, et al. Non-vitamin K antagonist oral anticoagulants for stroke prevention in asian patients with nonvalvular atrial fibrillation: meta-analysis. Stroke. 2015;46:2555–2561. [published Online First: 2015/08/26].
   PubMed Web of Science ®Google Scholar
• Lip GYH, Keshishian A, Li X, et al. Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients. Stroke. 2018;49:2933–2944. [published Online First: 2018/12/21].
   PubMed Web of Science ®Google Scholar
• Van Ganse E, Danchin N, Mahé I, et al. Comparative safety and effectiveness of oral anticoagulants in nonvalvular atrial fibrillation: the NAXOS study. Stroke. 2020;51:2066–2075. [published Online First: 2020/06/17].
   PubMed Web of Science ®Google Scholar
• Potpara TS, Ferro CJ, Lip GYH. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction. Nat Rev Nephrol. 2018;14:337–351. [published Online First: 2018/03/27].
   PubMed Web of Science ®Google Scholar
• Ha JT, Neuen BL, Cheng LP, et al. Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis. Ann Intern Med. 2019;171:181–189. [published Online First: 2019/07/16].
   PubMed Web of Science ®Google Scholar
• Kumar S, Lim E, Covic A, et al. Anticoagulation in concomitant chronic kidney disease and atrial fibrillation: JACC review topic of the week. J Am Coll Cardiol. 2019;74:2204–2215. [published Online First: 2019/10/28].
   PubMed Web of Science ®Google Scholar
• Murthy SB, Gupta A, Merkler AE, et al. Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis. Stroke. 2017;48:1594–1600. [published Online First: 2017/04/19].
   PubMed Web of Science ®Google Scholar
• Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994;89:635–641. [published Online First: 1994/02/01].
   PubMed Web of Science ®Google Scholar
• Li YG, Lip GYH. Anticoagulation resumption after intracerebral hemorrhage. Curr Atheroscler Rep. 2018;20:32. [published Online First: 2018/05/22].
   PubMed Web of Science ®Google Scholar
• Paciaroni M, Agnelli G, Falocci N, et al. Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study. Stroke. 2015;46:2175–2182. [published Online First: 2015/07/02].
   PubMed Web of Science ®Google Scholar
• Paciaroni M, Agnelli G, Ageno W, et al. Timing of anticoagulation therapy in patients with acute ischaemic stroke and atrial fibrillation. Thromb Haemost. 2016;116:410–416. [published Online First: 2016/06/28].
   PubMed Web of Science ®Google Scholar
• King BT, Lawrence PD, Milling TJ, et al. Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): methodology of a pragmatic, response-adaptive, prospective randomized clinical trial. Int J Stroke. 2019; 14:977–982. [published Online First: 2019/08/20].
   PubMed Web of Science ®Google Scholar
• Åsberg S, Hijazi Z, Norrving B, et al. Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial. Trials. 2017;18:581. [published Online First: 2017/12/05].
   PubMedGoogle Scholar
• Optimal timing of anticoagulation after acute ischaemic stroke : a randomised controlled trial (OPTIMAS). [cited 2020 Jul 20]. Available from: https://clinicaltrials.gov/ct2/show/NCT03759938
   Google Scholar
• Early versus late initiation of direct oral anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial (ELAN). [cited 2020 Aug 26]. Available from: https://clinicaltrials.gov/ct2/show/NCT03148457
   Google Scholar
• Shehab A, Bhagavathula AS, Abebe TB, et al. Patient adherence to novel oral anticoagulants (NOACs) for the treatment of atrial fibrillation and occurrence of associated bleeding events: a systematic review and meta-analysis. Curr Vasc Pharmacol. 2019;17:341–349. [published Online First: 2018/01/24].
   PubMed Web of Science ®Google Scholar
• Raparelli V, Proietti M, Cangemi R, et al. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants. Thromb Haemost. 2017;117:209–218. [published Online First: 2016/11/11].
   PubMed Web of Science ®Google Scholar
• Hwang J, Han S, Bae HJ, et al. NOAC adherence of patients with atrial fibrillation in the real world: dosing frequency matters? Thromb Haemost. 2020;120:306–313. [published Online First: 2019/10/30].
   PubMed Web of Science ®Google Scholar
• Banerjee A, Benedetto V, Gichuru P, et al. Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study. Heart. 2020;106:119–126. [published Online First: 2019/10/12].
   PubMed Web of Science ®Google Scholar
• Proietti M, Lane DA. The compelling issue of nonvitamin K antagonist oral anticoagulant adherence in atrial fibrillation patients: a systematic need for new strategies. Thromb Haemost. 2020;120:369–371. [published Online First: 2020/03/07].
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Ezzeddine MA, Nasar A, et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25:32–38. [published Online First: 2006/12/13].
   PubMed Web of Science ®Google Scholar
• Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke. 1986;17:861–864. [published Online First: 1986/09/01].
   PubMed Web of Science ®Google Scholar
• Ishitsuka K, Kamouchi M, Hata J, et al. High blood pressure after acute ischemic stroke is associated with poor clinical outcomes: fukuoka stroke registry. Hypertension (Dallas, Tex : 1979). 2014;63:54–60. [published Online First: 2013/10/16].
   Google Scholar
• Vemmos KN, Tsivgoulis G, Spengos K, et al. Association between 24-h blood pressure monitoring variables and brain oedema in patients with hyperacute stroke. J Hypertens. 2003;21(11):2167–2173. [published Online First: 2003/11/05].
   PubMed Web of Science ®Google Scholar
• Yong M, Kaste M. Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial. Stroke. 2008;39:366–372. [published Online First: 2007/12/22].
   PubMed Web of Science ®Google Scholar
• Leonardi-Bee J, Bath PM, Phillips SJ, et al. Blood pressure and clinical outcomes in the international stroke trial. Stroke. 2002;33:1315–1320. [published Online First: 2002/05/04].
   PubMed Web of Science ®Google Scholar
• Castillo J, Leira R, García MM, et al. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke. 2004;35:520–526. [published Online First: 2004/01/17].
   PubMed Web of Science ®Google Scholar
• Manning LS, Rothwell PM, Potter JF, et al. Prognostic significance of short-term blood pressure variability in acute stroke: systematic review. Stroke. 2015; 46:2482–2490. [published Online First: 2015/08/06].
   PubMed Web of Science ®Google Scholar
• González-Martínez F, Navarro-Gutierrez S, de León-belmar J. Initial emergency department blood pressure as predictor of survival after acute ischemic stroke. Neurology. 2006;66:1609;author reply 09. [published Online First: 2006/05/24].
   PubMed Web of Science ®Google Scholar
• Talke PO, Sharma D, Heyer EJ, et al. Republished: society for neuroscience in anesthesiology and critical care expert consensus statement: anesthetic management of endovascular treatment for acute ischemic stroke. Stroke. 2014;45:e138–50. [published Online First: 2014/07/30].
   PubMed Web of Science ®Google Scholar
• Löwhagen Hendén P, Rentzos A, Karlsson JE, et al. Hypotension during endovascular treatment of ischemic stroke is a risk factor for poor neurological outcome. Stroke. 2015;46:2678–2680. [published Online First: 2015/07/16].
   PubMed Web of Science ®Google Scholar
• John S, Hazaa W, Uchino K, et al. Lower intraprocedural systolic blood pressure predicts good outcome in patients undergoing endovascular therapy for acute ischemic stroke. Interv Neurol. 2016;4:151–157. [published Online First: 2016/04/07].
   PubMed Web of Science ®Google Scholar
• Abou-Chebl A, Zaidat OO, Castonguay AC, et al. North American SOLITAIRE stent-retriever acute stroke registry: choice of anesthesia and outcomes. Stroke. 2014;45:1396–1401. [published Online First: 2014/03/29].
   PubMed Web of Science ®Google Scholar
• Davis MJ, Menon BK, Baghirzada LB, et al. Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology. 2012;116:396–405. [published Online First: 2012/01/10].
   PubMed Web of Science ®Google Scholar
• Treurniet KM, Berkhemer OA, Immink RV, et al. A decrease in blood pressure is associated with unfavorable outcome in patients undergoing thrombectomy under general anesthesia. J Neurointerv Surg. 2018;10:107–111. [published Online First: 2017/04/14].
   PubMed Web of Science ®Google Scholar
• Whalin MK, Halenda KM, Haussen DC, et al. Even small decreases in blood pressure during conscious sedation affect clinical outcome after stroke thrombectomy: an analysis of hemodynamic thresholds. AJNR Am J Neuroradiol. 2017;38:294–298. [published Online First: 2016/11/05].
   PubMed Web of Science ®Google Scholar
• Simonsen CZ, Yoo AJ, Sørensen LH, et al. Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial. JAMA Neurol. 2018;75:470–477. [published Online First: 2018/01/18].
   PubMed Web of Science ®Google Scholar
• Schönenberger S, Uhlmann L, Hacke W, et al. Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. Jama. 2016;316:1986–1996. [published Online First: 2016/10/28].
   PubMed Web of Science ®Google Scholar
• Löwhagen Hendén P, Rentzos A, Karlsson JE, et al. General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: the anstroke trial (anesthesia during stroke). Stroke. 2017;48:1601–1607. [published Online First: 2017/05/20].
   PubMed Web of Science ®Google Scholar
• Sørensen LH, Speiser L, Karabegovic S, et al. Safety and quality of endovascular therapy under general anesthesia and conscious sedation are comparable: results from the GOLIATH trial. J Neurointerv Surg. 2019;11:1070–1072. [published Online First: 2019/03/31].
   PubMed Web of Science ®Google Scholar
• Delgado-Mederos R, Ribo M, Rovira A, et al. Prognostic significance of blood pressure variability after thrombolysis in acute stroke. Neurology. 2008;71:552–558. [published Online First: 2008/06/14].
   PubMed Web of Science ®Google Scholar
• Maier IL, Tsogkas I, Behme D, et al. High systolic blood pressure after successful endovascular treatment affects early functional outcome in acute ischemic stroke. Cerebrovasc Dis. 2018;45:18–25. [published Online First: 2017/11/28].
   PubMed Web of Science ®Google Scholar
• Berge E, Cohen G, Lindley RI, et al. Effects of blood pressure and blood pressure-lowering treatment during the first 24 hours among patients in the third international stroke trial of thrombolytic treatment for acute ischemic stroke. Stroke. 2015;46:3362–3369. [published Online First: 2015/10/22].
   PubMed Web of Science ®Google Scholar
• Ahmed N, Wahlgren N, Brainin M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from safe implementation of thrombolysis in stroke-international stroke thrombolysis register (SITS-ISTR). Stroke. 2009;40:2442–2449. [published Online First: 2009/05/23].
   PubMed Web of Science ®Google Scholar
• Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010;41:2254–2258. [published Online First: 2010/09/11].
   PubMed Web of Science ®Google Scholar
• Zaidat OO, Yoo AJ, Khatri P, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44:2650–2663. [published Online First: 2013/08/08].
   PubMed Web of Science ®Google Scholar
• Goyal N, Tsivgoulis G, Pandhi A, et al. Blood pressure levels post mechanical thrombectomy and outcomes in large vessel occlusion strokes. Neurology. 2017;89:540–547. [published Online First: 2017/07/09].
   PubMed Web of Science ®Google Scholar
• Meloni BP, South SM, Gill DA, et al. Poly-arginine peptides r18 and r18d improve functional outcomes after endothelin-1-induced stroke in the sprague dawley rat. J Neuropathol Exp Neurol. 2019;78:426–435. [published Online First: 2019/03/20].
   PubMed Web of Science ®Google Scholar
• Dabrowska S, Andrzejewska A, Lukomska B, et al. Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles. J Neuroinflammation. 2019;16:178. [published Online First: 2019/09/14].
   PubMed Web of Science ®Google Scholar
• Henriksson R, Björklund F, Mooe T. The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction. PloS One. 2019;14:e0216404. [published Online First: 2019/05/07].
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin Y, Meng X, et al. Effect of ticagrelor with clopidogrel on high on-treatment platelet reactivity in acute stroke or transient ischemic attack (PRINCE) trial: rationale and design. Int J Stroke. 2017;12:321–325. [published Online First: 2017/04/07].
   PubMed Web of Science ®Google Scholar
• Stringberg A, Camden R, Qualls K, et al. Update on dual antiplatelet therapy for secondary stroke prevention. Mo Med. 2019;116:303–307. [published Online First: 2019/09/19].
   PubMedGoogle Scholar
• Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PloS One. 2016;11:e0158765. [published Online First: 2016/07/08].
   PubMed Web of Science ®Google Scholar
• Kulkarni N, Gukathasan N, Sartori S, et al. Chronic kidney disease and atrial fibrillation: a contemporary overview. J Atr Fibrillation. 2012;5:448. [published Online First: 2012/06/15].
   PubMedGoogle Scholar
• Baber U, Howard VJ, Halperin JL, et al. Association of chronic kidney disease with atrial fibrillation among adults in the United States: rEasons for geographic and racial differences in stroke (REGARDS) study. Circ Arrhythm Electrophysiol. 2011;4:26–32. [published Online First: 2010/11/16].
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang X, Dong L, et al. The many roles of statins in ischemic stroke. Curr Neuropharmacol. 2014;12:564–574. [published Online First: 2015/05/16].
   PubMed Web of Science ®Google Scholar
• Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120(3):472–495. [published Online First: 2017/02/06].
   PubMed Web of Science ®Google Scholar
• Wang L, Wang Z, Shi J, et al. Inhibition of proprotein convertase subtilisin/kexin type 9 attenuates neuronal apoptosis following focal cerebral ischemia via apolipoprotein E receptor 2 downregulation in hyperlipidemic mice. Int J Mol Med. 2018;42:2098–2106. [published Online First: 2018/08/02].
   PubMed Web of Science ®Google Scholar
• Christophe B, Karatela M, Sanchez J, et al. Statin therapy in ischemic stroke models: a meta-analysis. Transl Stroke Res. 2020;11:590–600. [published Online First: 2019/12/04].
   PubMed Web of Science ®Google Scholar
• Borghese O, Pisani A, Lapergue B, et al. Early carotid endarterectomy for symptomatic stenosis of internal carotid artery in patients affected by transient ischemic attack or minor-to-moderate ischemic acute stroke: a single-center experience. Ann Vasc Surg. 2020;65:232–239. [published Online First: 2019/11/11].
   PubMed Web of Science ®Google Scholar
• Farouk M, Sato K, Matsumoto Y, et al. Endovascular treatment of internal carotid artery dissection presenting with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2020;29:104592. [published Online First: 2019/12/31].
   PubMed Web of Science ®Google Scholar
• Mojadidi MK, Zaman MO, Elgendy IY, et al. Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol. 2018;71:1035–1043. published Online First: 2018/03/03].
   PubMed Web of Science ®Google Scholar